Pulsenmore develops and commercializes portable, hand-held ultrasound devices designed for self-administered or telehealth-guided home scanning, enabling patients to perform non-invasive diagnostic imaging without medical training. The company's primary product is a clinically validated prenatal ultrasound device that allows pregnant women to monitor fetal development from home, with additional products in development for fertility treatment monitoring and chronic disease management. Revenue is generated through device sales to healthcare providers and health maintenance organizations, supplemented by emerging subscription-based software services that enable remote image transmission to clinicians and data analytics platforms.